Institutional Manager · CIK 0001617201
Prosight Management, LP
DALLAS, TX · File #028-18450
Latest AUM
$483.9M
Positions
38
Top-10 Concentration
57.2%
Filings
9
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| ADD | PROCEPT BIOROBOTICS CORP | PRCT | +1,303,009 | +$41.0M | -$325,672 |
| NEW | NEKTAR THERAPEUTICS | NKTR | +554,633 | +$23.4M | $0 |
| EXITED | INTUITIVE SURGICAL INC | 46120E602 | -48,711 | -$21.8M | $0 |
| ADD | JANUX THERAPEUTICS INC | JANX | +1,527,173 | +$21.1M | -$9.2M |
| NEW | VEEVA SYS INC | VEEV | +90,133 | +$20.1M | $0 |
| REDUCE | BRIDGEBIO PHARMA INC | BBIO | -234,500 | -$17.9M | +$6.5M |
| NEW | PHREESIA INC | PHR | +977,152 | +$16.5M | $0 |
| REDUCE | ROIVANT SCIENCES LTD | ROIV | -708,338 | -$15.4M | +$8.8M |
| EXITED | DEXCOM INC | 252131107 | -195,217 | -$13.1M | $0 |
| ADD | BOSTON SCIENTIFIC CORP | BSX | +133,900 | +$12.8M | -$173,508 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202538 pos · $483.9M
- 13F HOLDINGS REPORTQ/E Sep 202544 pos · $428.8M
- 13F HOLDINGS REPORTQ/E Jun 202539 pos · $410.1M
- 13F HOLDINGS REPORTQ/E Mar 202538 pos · $304.3M
- 13F HOLDINGS REPORTQ/E Dec 202436 pos · $361.8M
- 13F HOLDINGS REPORTQ/E Sep 202447 pos · $406.4M
- 13F HOLDINGS REPORTQ/E Jun 202446 pos · $334.6M
- 13F HOLDINGS REPORTQ/E Mar 202444 pos · $359.5M
- 13F HOLDINGS REPORTQ/E Dec 202341 pos · $315.5M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | PROCEPT BIOROBOTICS CORP | PRCT | 1,380,000 | $43.4M | 8.97% |
| 2 | GALAPAGOS NV | GLPGF | 1,074,112 | $35.1M | 7.26% |
| 3 | JANUX THERAPEUTICS INC | JANX | 2,392,523 | $33.0M | 6.82% |
| 4 | ADC THERAPEUTICS SA | ADCT | 8,477,338 | $29.9M | 6.18% |
| 5 | KURA ONCOLOGY INC | KURA | 2,529,600 | $26.3M | 5.43% |
| 6 | MEIRAGTX HLDGS PLC | MGTX | 3,209,788 | $25.5M | 5.27% |
| 7 | NEKTAR THERAPEUTICS | NKTR | 554,633 | $23.4M | 4.85% |
| 8 | VEEVA SYS INC | VEEV | 90,133 | $20.1M | 4.16% |
| 9 | ICON PLC | ICLR | 110,000 | $20.0M | 4.14% |
| 10 | BOSTON SCIENTIFIC CORP | BSX | 210,000 | $20.0M | 4.14% |
| 11 | CONCENTRA GROUP HOLDINGS PAR | CON | 891,030 | $17.5M | 3.62% |
| 12 | PHREESIA INC | PHR | 977,152 | $16.5M | 3.42% |
| 13 | AMICUS THERAPEUTICS INC | FOLD | 1,150,000 | $16.4M | 3.38% |
| 14 | SELECT MED HLDGS CORP | 81619Q105 | 1,035,086 | $15.4M | 3.18% |
| 15 | SYNDAX PHARMACEUTICALS INC | SNDX | 665,000 | $14.0M | 2.89% |
| 16 | ZYMEWORKS INC | ZYME | 530,393 | $14.0M | 2.89% |
| 17 | ROIVANT SCIENCES LTD | ROIV | 627,162 | $13.6M | 2.81% |
| 18 | CRINETICS PHARMACEUTICALS IN | CRNX | 262,904 | $12.2M | 2.53% |
| 19 | AVANTOR INC | AVTR | 898,499 | $10.3M | 2.13% |
| 20 | SHATTUCK LABS INC | STTK | 2,381,502 | $8.7M | 1.80% |